global combinations use acellular pertussis

Sanofi is a global healthcare leader and one of the world's largest vaccine manufacturers through its dedicated business unit, Sanofi Pasteur. The company is a pioneer in the development of acellular pertussis (aP) vaccines, which are integrated into complex pediatric combination vaccines to reduce the number of injections for infants. Their portfolio includes key global brands such as Pentacel, Vaxelis (developed in partnership with Merck), and Hexaxim/Hexyon, which provide protection against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B. Sanofi continues to focus on expanding the reach of these acellular pertussis-based combinations in both developed and emerging markets to replace older whole-cell pertussis formulations.